Paper205351
Abnormal distribution of O-alkyl groups in the neutral glycerolipids from human hepatocellular carcinomas.
Lin HJ and 2 others. Cancer Res, 1978. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. Abnormal distribution of O-alkyl groups in the neutral glycerolipids from human hepatocellular carcinomas. Papers, record 205351. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/205351
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Abnormal distribution of O-alkyl groups in the neutral glycerolipids from human hepatocellular carcinomas.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Glycerides | Major topic |
| Glycolipids | Major topic |
| Liver Neoplasms | Major topic |
| Cholesterol | |
| Humans | |
| Liver |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 28890136 | Identification of lipidomic markers of chronic 3,3',4,4',5-pentachlorobiphenyl (PCB 126) exposure in the male rat liver. | Toxicology | 2017 | https://conductscience.org/library/papers/28890136 | PubMed |
| 22771767 | Orphan enzymes in ether lipid metabolism. | Biochimie | 2013 | https://conductscience.org/library/papers/22771767 | PubMed |
| 21513884 | A potent and selective inhibitor of KIAA1363/AADACL1 that impairs prostate cancer pathogenesis. | Chem Biol | 2011 | https://conductscience.org/library/papers/21513884 | PubMed |
| 20948908 | An update on the therapeutic role of alkylglycerols. | Mar Drugs | 2010 | https://conductscience.org/library/papers/20948908 | PubMed |
| 18046593 | A reliable biomarker derived from plasmalogens to evaluate malignancy and metastatic capacity of human cancers. | Lipids | 2008 | https://conductscience.org/library/papers/18046593 | PubMed |
| 7059692 | Antineoplastic activity of synthetic lysophospholipid analogs. | Blut | 1982 | https://conductscience.org/library/papers/7059692 | PubMed |
| 6594705 | Tumorigenicity of cell lines with altered lipid composition. | Proc Natl Acad Sci U S A | 1984 | https://conductscience.org/library/papers/6594705 | PubMed |
| 6245673 | The ether lipid tumour marker in human liver with hepatocellular carcinoma. | Br J Cancer | 1980 | https://conductscience.org/library/papers/6245673 | PubMed |
| 4044645 | Biochemical studies on cell fusion. I. Lipid composition of fusion-resistant cells. | J Cell Biol | 1985 | https://conductscience.org/library/papers/4044645 | PubMed |
| 3328026 | Biosynthesis and biotransformation of ether lipids. | Lipids | 1987 | https://conductscience.org/library/papers/3328026 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/205351
GET https://conductscience.org/api/papers/v1/205351/authors